2024. Immune-Related Adverse Events After Combination Checkpoint Blockade: A Short Communication on Steroid-Sparing Practice. Translational Medicine & Therapeutics Journal. 3, 2 (Dec. 2024), 110–119. DOI:https://doi.org/10.5281/zenodo.22649312.